Expressing her love for boyfriend Genasis
, the model shared a heartfelt post in December.
Reportedly, the GenASIs
automated imaging platforms for pathology and genetic analysis provide advanced diagnostic aids for pathologists and cytogeneticists, with reproducible and reliable results.
platforms can be used with any brand of brightfield or fluorescence microscope, and support manual and automatic scanning for a range of workflows and applications, to best suit the needs, size and budget of any lab.
HiPath IHC Family is an advanced image analysis platform for IHC samples that integrates with existing lab microscopes and workflows, providing labs with a cost-effective solution for digital pathology.
advanced cytogenetic and pathology platforms are the foundation of ASI's offering, ASI provides diagnostic aids, offering cytogeneticists and pathologists biomedical analysis.
-- right before moving to mingle and pose for photos with his fans.
Food and Drug Administration (FDA) for its GenASIs
HiPath image capture and analysis platform.
M2 PHARMA-February 20, 2012-ASI's GenASIs
advanced imaging for HER-2/neu analysis cleared by FDA(C)2012 M2 COMMUNICATIONS
(ASI) and Biocare Medical, LLC (Biocare) announced today the signing of a strategic partnership agreement in which Biocare will distribute ASI's IHC and CISH imaging and analysis solution, GenASIs
Pathology, in the United States.
have entered into an agreement in which both companies will engage in combined sales and marketing of an integration product that will directly link the GenASIs
imaging and analysis instrument by ASI and the CellWriter[TM] automated dispensing system for FISH and Karyotyping by BioDot.
have entered into an agreement in which both companies will engage in combined sales and marketing of the GenASIs
imaging and analysis instrument by ASI and the EpiSEP cell recovery and enrichment solution by WaveSense.
Carlsbad, CA, February 16, 2013 --(PR.com)-- Applied Spectral Imaging (ASI, www.spectral-imaging.com) announced today that its GenASIs
Scan & Analysis automated microscopy platform has received FDA clearance as an aid in ALK gene analysis for lung cancer therapy selection.